Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Niger J Clin Pract ; 26(9): 1319-1325, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37794545

ABSTRACT

Background: Sepsis monitoring tissue perfusion is crucial for detecting circulatory failure early, implementing the right treatments, and assessing response. Insufficient oxygenation leads to a rise in lactate level and has been shown to be useful in predicting mortality and morbidity in newborns. There have not been many studies on how lactate measurement affects neonatal sepsis diagnosis and prognosis. Aim: The aim of our study was to determine the impact of lactate on early diagnosis and prognosis in neonatal sepsis. Materials and Methods: Eighty-seven newborns diagnosed with neonatal sepsis at a neonatal intensive care unit between January 2010 and July 2021 were included in the study. Venous blood gas, lactate, and C-reactive protein (CRP) levels and complete blood count on the first, second, and third day of hospitalization were noted. Lactate values were correlated with other variables to determine the impact of hyperlactatemia on morbidity and to determine factors affecting the length of stay. IBM SPSS Statistics version 22.0 for Windows was used to analyze the data (SPSS Inc., Chicago, IL, United States). Results: A strong negative correlation between lactate and oxygenation and perfusion indicators (HCO3, BE, PaO2) during the therapeutic process was observed. With treatment, the initial measured lactate value decreased, and a significant increase in CRP and oxygen saturation was observed, which was interpreted as the observation of an early lactate response to infection before a CRP response. The initial lactate level, as well as the change in lactate levels, was not, however, significantly correlated with the length of stay. Conclusion: Lactate can be used in the early diagnosis of neonatal sepsis and for determining prognosis.


Subject(s)
Neonatal Sepsis , Sepsis , Infant, Newborn , Humans , Neonatal Sepsis/diagnosis , Lactic Acid , C-Reactive Protein/analysis , Prognosis , Early Diagnosis
2.
G Chir ; 39(2): 82-86, 2018.
Article in English | MEDLINE | ID: mdl-29694306

ABSTRACT

INTRODUCTION: Synchronous colon and gastric cancer is a rare clinical entity. In the present case, it is aimed to show that in a patient with synchronous colon and gastric cancer, laparoscopic resection can be safely performed and both specimens can be delivered through a natural orifice. In our knowledge, this is the first example showing the delivery of the gastric resection specimen through the anus in a human being. CASE REPORT: Sixty-six years old male patient with an upper gastrointestinal bleeding and obstruction symptoms was admitted to our department and the evaluation revealed an advanced stage gastric and a synchronous colon cancer. A laparoscopic palliative subtotal gastrectomy with a subtotal colectomy was performed. All anastomoses were performed intracorporeally and colectomy and subtotal gastrectomy specimens were successfully delivered via trans-anal route without any difficulty. Despite major abdominal organ resections, the patients required quite less analgesics in the postoperative period. DISCUSSION: Specimen extraction through the natural orifices eliminates the need and problems of performing additional abdominal incisions to the patients which also leads to reduced postoperative pain. Synchronous surgical procedures do not prevent the natural orifice surgery.


Subject(s)
Adenocarcinoma/surgery , Cecal Neoplasms/surgery , Colectomy/methods , Gastrectomy/methods , Natural Orifice Endoscopic Surgery/methods , Neoplasms, Multiple Primary/surgery , Sigmoid Neoplasms/surgery , Specimen Handling/methods , Stomach Neoplasms/surgery , Adenocarcinoma/pathology , Aged , Anal Canal , Cecal Neoplasms/pathology , Humans , Male , Neoplasms, Multiple Primary/pathology , Palliative Care , Sigmoid Neoplasms/pathology , Stomach Neoplasms/pathology
3.
Immunol Invest ; 46(1): 10-21, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27611810

ABSTRACT

In this study, we aimed to explore the association among gene variants of five cytokines, tumor necrosis factor alpha (TNF-α), transforming growth factor beta-1 (TGF-ß1), interferon gamma (IFN-γ), interleukin-6 (IL-6), and interleukin-10 (IL-10), and clinical parameters and prognosis in patients with multiple myeloma (MM) treated with novel therapeutic drugs in Turkish population for the first time except TNF-α. We analyzed five cytokine genes in 113 cases with MM and 113 healthy controls. Cytokine genotyping was performed by the polymerase chain reaction-sequence-specific primer method (PCR-SSP). AG genotype associated with high expression in TNF-α gene (-308) variant was found to be significantly higher (p = 0.019), and GG genotype associated with low expression in TNF-α gene (-308) variant was significantly lower in MM group as compared with controls (p = 0.012). IFN-γ (+874) variant TT genotype was increased (p = 0.037), and AA genotype was decreased (p = 0.002) in MM group in contrast to controls. IFN-γ (+874) T allele was higher in MM patients compared with controls (OR = 1.985, p = 0.000), while A allele was significantly lower (OR = 0.5037, p = 0.0005). Multivariate analysis revealed that factors associated with 5-year overall survival (OS) were only IPI III (RR = 1.630, p = 0.018) and thrombocytopenia (RR = 2.207, Cox p = 0.021), while 5-year event-free survival (EFS) was associated with IPI III (RR = 1.524, p = 0.022), thrombocytopenia (RR = 2.902, p = 0.002), APSCT treatment (RR = 1.729, p = 0.035), and female gender (RR = 0.435, p = 0.002) with negative prognostic values. Our results suggested that TNF-α gene (-308) AG genotype and IFN-γ (+874) TT genotype and T allele may have a role on MM, while other cytokines were not associated with the risk of MM.


Subject(s)
Interferon-gamma/genetics , Interleukin-10/genetics , Interleukin-6/genetics , Multiple Myeloma/genetics , Thrombocytopenia/genetics , Transforming Growth Factor beta1/genetics , Tumor Necrosis Factor-alpha/genetics , Case-Control Studies , Female , Gene Frequency , Genotype , Humans , Male , Multiple Myeloma/mortality , Sex Factors , Survival Analysis , Thrombocytopenia/mortality , Turkey
4.
Acta Gastroenterol Belg ; 73(4): 521-6, 2010.
Article in English | MEDLINE | ID: mdl-21299166

ABSTRACT

A 43-year old male patient with hyponatremic hypertensive syndrome was diagnosed as catastrophic primary antiphospholipid syndrome (PAPS). He subsequently developed hepatosplenomegaly. The patient also carried thrombophilia- and haemochromatosis-associated gene mutations. Further investigations upon persistence of splenomegaly indicated development of idiopathic portal hypertension.


Subject(s)
Antiphospholipid Syndrome/complications , Hypertension, Portal/etiology , Acute Disease , Adult , Antiphospholipid Syndrome/diagnosis , Antiphospholipid Syndrome/physiopathology , Humans , Hypertension/complications , Hyponatremia/complications , Male , Renal Artery Obstruction/complications , Splenomegaly/complications , Venous Thrombosis/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...